Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Fritz, M; Fritsch, P; Foramitti, M; Simma, B.
Pulse oximetry screening of neonates for critical congenital heart disease
MONATSSCHR KINDERH. 2014; 162(7): 638-643.
Doi: 10.1007/s00112-014-3149-y
Web of Science
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Fritsch Peter
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Congenital heart defects occur with a prevalence of approximately 7-12 per 1000 live births and are responsible for up to 20 % of fatalities of newborn infants. Conventional screening procedures, such as prenatal diagnostics and postnatal clinical examinations can still only detect critical congenital heart disease with insufficient sensitivity and specificity. The international trend to early hospital discharge of newborn infants increases the risk of not diagnosing critical congenital heart disease during the postpartum hospitalization period, which results in the necessity for new strategies for early recognition of these diseases. Pulse oximetry screening (POS) could be confirmed as a simple, painless, easily available, economic, highly specific and sufficiently sensitive supplementary procedure for the recognition of critical congenital heart disease. This article describes the recommendations of the working group for pediatric cardiology and neonatology/pediatric intensive care medicine of the Austrian Society for Pediatrics and Adolescent Medicine on carrying out POS.
- Find related publications in this database (Keywords)
-
Cyanosis
-
Neonatal screening
-
Diagnosis, prenatal
-
Sensitivity and specificity
-
Costs and cost analysis